Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7645 USD | -5.95% | +2.80% | -62.52% |
Apr. 15 | Nature Medicine Publishes Interim Results from Gritstone Bio's Phase 1/2 Study of "Off-The-Shelf" Neoantigen Vaccine Platform | CI |
Apr. 02 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.52% | 86.49M | |
-4.63% | 87.31B | |
+2.63% | 40.86B | |
-21.76% | 29.36B | |
+58.56% | 24.49B | |
-14.78% | 17.31B | |
-18.49% | 11.62B | |
-15.61% | 11.31B | |
-44.02% | 11.26B | |
+5.17% | 8.31B |
- Stock Market
- Equities
- GRTS Stock
- News Gritstone bio, Inc.
- HC Wainwright Adjusts Gritstone Bio's Price Target to $15 From $24, Maintains Buy Rating